ArticlePloS one2016

Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer.

Bo Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.